Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Kawase, M. Takaoka, S. Miyamoto, H. Ohnishi, T. Kubota, T. Namikawa, K. Hanazaki, A. Yokoyama (Nankoku, Japan). Low lung volume is associated with visceral adipose tissue inflammation. Eur Respir J 2013; 42: Suppl. 57, 3428

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Mast cell markers in adipose tissue, systemic inflammation and asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Adipokines in end-stage lung diseases: The crosstalk between bone and adipose tissue Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis Source: International Congress 2016 – Connective tissue disorders Year: 2016 Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Characterisation of adipose tissue macrophage phenotypes in obese asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Metabolic syndrome and visceral adipose tissue (VAT) are associated with obstructive and restrictive lung function impairment. Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020 Lung function impairment in adult asthma increases the risk of systemic inflammation Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Presence of progranulin in airway inflammation associated with COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Different response of lung tissue to intravenous acetylated opium Source: International Congress 2015 – Different data in COPD Year: 2015 Evaluation of the role of inflammation in chronic airways disease (ERICA): Midpoint evaluation Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Metalloproteases gene expression and remodeling of lung parenchyma fibers during the progression of elastase induced emphysema Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Scleroderma lung disease: A scleroderma physiologic index (SPI) derived from lung physiology and oxygen saturation Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Chemical exposure triggering connective tissue disease with lung involvement Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients Source: International Congress 2016 – From microimaging to functional evaluation of the lung Year: 2016 Role of serum and tissue vascular remodeling markers in bone loss related to end-stage COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders Source: International Congress 2014 – IPF and surroundings Year: 2014 The effects of mesechymal cells isolated from abdominal adipose tissue on rat model of emphysema Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more Year: 2014